
CHE Earnings
Chemed Corp
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of Chemed Corp(CHE) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Chemed Corp earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
FY2025Q2 | 2025-07-29 | After Hours | 4.91 | 4.27 | -13.03 | 623.93M | 618.80M | -0.82 | -10.36 | -8.90 |
FY2025Q1 | 2025-04-23 | After Hours | 5.55 | 5.63 | +1.44 | 641.78M | 646.94M | +0.80 | -6.61 | -1.79 |
FY2024Q4 | 2025-02-26 | After Hours | 6.78 | 6.83 | +0.74 | 636.10M | 639.99M | +0.61 | +7.39 | +9.05 |
FY2024Q3 | 2024-10-29 | After Hours | 5.76 | 5.64 | -2.08 | 612.22M | 606.18M | -0.99 | -12.14 | -12.57 |
FY2024Q2 | 2024-07-24 | - | 5.14 | 5.01 | -2.53 | 599.20M | 595.88M | -0.55 | +1.14 | +4.59 |
FY2024Q1 | 2024-04-24 | - | 5.09 | 4.68 | -8.06 | 591.10M | 589.23M | -0.32 | +0.23 | -7.87 |
FY2023Q4 | 2024-02-27 | - | 6.25 | 6.60 | +5.60 | 586.64M | 585.91M | -0.12 | -0.31 | +5.61 |
FY2023Q3 | 2023-10-25 | - | 4.92 | 5.32 | +8.13 | 558.42M | 564.53M | +1.10 | -0.02 | +10.95 |
FY2023Q2 | 2023-07-26 | - | 5.09 | 4.71 | -7.47 | 562.54M | 553.82M | -1.55 | +0.04 | -8.02 |
- | 2023-04-26 | - | 4.38 | 4.39 | +0.23 | - | - | - | -0.82 | -3.01 |
CHE Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Chemed Corp reported performance for FY2025Q2, announced on 2025-07-29. The company achieved an EPS of 4.27, compared to analyst estimates of 4.91 by -13.03% . Revenue for the quarter reached 618.80M compared to expectations of 623.93M by -0.82% .
The stock price reacted with a -10.36% one-day change and a -8.90% five-day change following the earnings release. These movements reflect market reaction in Chemed Corp growth trajectory and strategic initiatives.
CHE Earnings Forecast
Looking ahead, Chemed Corp(CHE) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q3 project quarter revenue of 629.36M and an EPS of 5.36.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Downward by -2.27%, while EPS estimates have been Revise Downward by -9.84%. For the upcoming Q3 2025, revenue estimates have been adjusted Revise Downward by -3.8% . These revisions correlate with a -24.07% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Chemed Corp long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between CHE's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Downward

-2.27%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-9.84%
In Past 3 Month
Revenue Estimates for Q3 2025
Revise Downward

-3.8%
In Past 3 Month
Stock Price
Go Down

-24.07%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:2.55B
--
EPS Estimate-Annual FY 2025:22.11
—
Stock Price432.14
CHE Revenue and EPS Performance: A Historical Perspective
Chemed Corp revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q2 (2025-07-29,After Hours):
EPS: 4.27 (Actual) vs.4.91 (Estimate) (-13.03%)
Revenue: 618.80M (Actual) vs. 623.93M (Estimate) (-0.82%)
Price Reaction: -10.36%(1-Day), -8.90%(5-Day)
FY2025Q1 (2025-04-23,After Hours):
EPS: 5.63 (Actual) vs.5.55 (Estimate) (1.44%)
Revenue: 646.94M (Actual) vs. 641.78M (Estimate) (0.80%)
Price Reaction: -6.61%(1-Day), -1.79%(5-Day)
FY2024Q4 (2025-02-26,After Hours):
EPS: 6.83 (Actual) vs.6.78 (Estimate) (0.74%)
Revenue: 639.99M (Actual) vs. 636.10M (Estimate) (0.61%)
Price Reaction: 7.39%(1-Day), 9.05%(5-Day)
Earnings Reaction
The chart below shows how CHE performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CHE sees a -1.38% change in stock price 10 days leading up to the earnings, and a +0.06% change 10 days following the report. On the earnings day itself, the stock moves by +0.03%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed -10.36% on the day following the earnings release and then changed by -7.00% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Chemed Corp (CHE) Q2 2025 Earnings Call Summary
Neutral
2025-07-30
The earnings call presents a mixed picture. Positive elements include VITAS's revenue growth and strategic acquisitions, while negative aspects involve declining Roto-Rooter EBITDA and margin concerns. The Q&A session revealed management's efforts to address issues but also highlighted uncertainties, particularly with Roto-Rooter and VITAS admissions. The lack of detailed guidance and unclear responses create uncertainty, balancing the positive impact of share buybacks and strategic focus. Overall, the sentiment is neutral as the positive and negative factors counterbalance each other, leading to an expected stock price movement within the -2% to 2% range.
Chemed Corp (CHE) Q1 2025 Earnings Call Summary
Positive
2025-04-24
The earnings call reveals strong financial performance for VITAS and Roto-Rooter, with significant revenue and EBITDA growth. Despite challenges like Medicare Cap and competitive pressures, the company has effective strategies to mitigate these risks. The absence of a share buyback program and slightly declining EBITDA margin for Roto-Rooter are minor concerns. The Q&A indicates management's confidence in handling cap issues and cash flow dynamics. Overall, the positive financial metrics and strategic initiatives outweigh the risks, suggesting a positive stock price movement.
Chemed Corp (CHE) Q4 2024 Earnings Call Summary
Neutral
2025-02-27
The earnings call presents mixed signals. Strong financial performance, optimistic guidance, and strategic growth initiatives are positives. However, challenges like margin pressures, competitive pressures on Roto-Rooter, and Medicare Cap limitations pose risks. The Q&A section highlighted management's confidence but also revealed uncertainties, particularly regarding marketing impacts and market entry timelines. The absence of a shareholder return plan further tempers positive sentiment. Overall, the factors balance out, leading to a neutral prediction for stock price movement over the next two weeks.
Chemed Corporation (CHE) Q3 2024 Earnings Call Summary
Neutral
2024-10-30
The earnings call reveals mixed signals. VITAS shows strong financial performance with significant revenue growth and increased EBITDA, but Roto-Rooter faces revenue declines and challenges from marketing transitions and competition. The shareholder return plan lacks buybacks or dividends, and EPS guidance is reduced, but still shows growth from the previous year. The Q&A section highlights cautious optimism for VITAS but ongoing issues for Roto-Rooter. Overall, the positives from VITAS balance the negatives from Roto-Rooter, leading to a neutral prediction for stock movement.
Chemed Corporation (CHE) Q2 2024 Earnings Call Summary
Neutral
2024-07-25
The earnings call reveals mixed signals: strong VITAS growth and optimistic guidance are countered by Roto-Rooter's revenue decline and competitive pressures. The lack of a shareholder return plan and unclear management responses further contribute to uncertainty. The company's expansion efforts and active acquisition pipeline provide potential upside, but risks like regulatory issues and economic factors temper enthusiasm. Overall, the sentiment is balanced, suggesting a neutral stock price reaction.
People Also Watch

PAC
Grupo Aeroportuario del Pacifico SAB de CV
243.490
USD
+1.07%

SKM
SK Telecom Co Ltd
22.470
USD
-0.84%

ASR
Grupo Aeroportuario del Sureste SAB de CV
312.830
USD
+0.59%

SARO
StandardAero, Inc.
28.310
USD
+2.68%

FSV
FirstService Corp
195.750
USD
-0.91%

KT
KT Corp
20.040
USD
-0.74%

LTM
LATAM Airlines Group SA
42.740
USD
-2.13%

AGI
Alamos Gold Inc
26.120
USD
-0.23%

MTCH
Match Group Inc
35.700
USD
-1.08%

FRHC
Freedom Holding Corp
175.000
USD
-1.85%
FAQ

What were the key highlights of CHE’s latest earnings report for FY2025Q2?
CHE reported its FY2025Q2 earnings on 2025-07-29, showcasing a revenue of 618.80M against an estimate of 623.93M, resulting in a -0.82% surprise. The EPS was 4.27, surpassing the expected 4.91 by -13.03% . The stock experienced a -10.36% price change on the earnings day and a -8.9% change over the next five days, reflecting market reactions to the results.

How did CHE’s stock price react after the FY2025Q2 earnings release?

What are the revenue and EPS estimates for CHE for 2025/Q3?

How does CHE’s stock price correlate with earnings forecast revisions?

What should investors expect from CHE’s next earnings report?
